Skip to content

Dysregulation of the Systemic and Local Hypothalamic-Pituitary-Adrenal (HPA) Axis in Stress-Associated Vitiligo and its Role in Melanocyte Dysfunction: Protocol for a Prospective Observational Study

Dysregulation of the Systemic and Local Hypothalamic-Pituitary-Adrenal (HPA) Axis in Stress-Associated Vitiligo and its Role in Melanocyte Dysfunction: Protocol for a Prospective Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124948
Enrollment
Unknown
Registered
2026-05-19
Start date
2026-06-11
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo

Interventions

Sponsors

The Fifth People's of Hainan Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Age 18–60 years. 2.Clinical diagnosis of non-segmental vitiligo. 3.Progressive group: VIDA score = +1; Stable group: VIDA score = 0 for =6 months. 4.Healthy controls: matched for age/sex, no autoimmune/endocrine/significant skin disease. 5.Willing to provide written informed consent and comply with study procedures.

Exclusion criteria

Exclusion criteria: 1.Use of systemic corticosteroids/immunosuppressants in past 3 months. 2.Known endocrine disorders affecting HPA axis. 3.Major psychiatric disorders or medications affecting HPA axis. 4.Hair dyeing/chemical treatment in past 3 months. 5.Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
HCC (Hair Cortisol Concentration);Serum cortisol;Adrenocorticotropic Hormone;Corticotropin-Releasing Hormone Receptor;Microphthalmia-Associated Transcription Factor;

Secondary

MeasureTime frame
Tyrosinase;

Countries

China

Contacts

Public ContactDanping Pan

The Fifth People's of Hainan Province

pandanping904@163.com+86 138 0757 9878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 20, 2026